NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GemVax&KAEL Co.Ltd (KQ: 082270)

 
082270 Technical Analysis
4
As on 21st Nov 2024 082270 STOCK Price closed @ 12480.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 13097.34 & Strong Sell for SHORT-TERM with Stoploss of 13960.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

082270STOCK Price

Open 13800.00 Change Price %
High 13810.00 1 Day -1280.00 -9.30
Low 12340.00 1 Week -420.00 -3.26
Close 12480.00 1 Month -7370.00 -37.13
Volume 503264 1 Year -2280.00 -15.45
52 Week High 22950.00 | 52 Week Low 9900.00
 
KQ Korea Most Active Stocks
001470 1274.00 30.00%
001470 1274.00 30.00%
082850 3320.00 5.73%
009810 345.00 14.24%
009810 345.00 14.24%
030530 2870.00 6.69%
217730 2685.00 18.81%
000040 670.00 12.42%
000040 670.00 12.42%
214870 1383.00 -27.44%
 
KQ Korea Top Gainers Stocks
001470 1274.00 30.00%
001470 1274.00 30.00%
002995 9710.00 29.99%
002995 9710.00 29.99%
002995 9710.00 29.99%
002410 3165.00 29.98%
002410 3165.00 29.98%
002410 3165.00 29.98%
065690 1900.00 29.96%
008830 10800.00 29.96%
 
KQ Korea Top Losers Stocks
318020 4195.00 -76.82%
097780 874.00 -74.18%
001529 2095.00 -73.81%
001529 2095.00 -73.81%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
091970 604.00 -62.48%
032860 1800.00 -50.55%
016385 10450.00 -37.05%
016385 10450.00 -37.05%
 
 
082270
Daily Charts
082270
Intraday Charts
Whats New @
Bazaartrend
082270
Free Analysis
 
082270 Important Levels Intraday
RESISTANCE15312.69
RESISTANCE14404.23
RESISTANCE13842.69
RESISTANCE13281.15
SUPPORT11678.85
SUPPORT11117.31
SUPPORT10555.77
SUPPORT9647.31
 
082270 Forecast November 2024
4th UP Forecast17740.7
3rd UP Forecast16053.6
2nd UP Forecast15010.7
1st UP Forecast13967.8
1st DOWN Forecast10992.2
2nd DOWN Forecast9949.29
3rd DOWN Forecast8906.43
4th DOWN Forecast7219.29
 
082270 Weekly Forecast
4th UP Forecast14368.46
3rd UP Forecast13762.82
2nd UP Forecast13388.46
1st UP Forecast13014.10
1st DOWN Forecast11945.90
2nd DOWN Forecast11571.54
3rd DOWN Forecast11197.18
4th DOWN Forecast10591.54
 
082270 Forecast2024
4th UP Forecast40305.9
3rd UP Forecast31382
2nd UP Forecast25865.9
1st UP Forecast20349.8
1st DOWN Forecast4610.2
2nd DOWN Forecast-905.88
3rd DOWN Forecast-6421.96
4th DOWN Forecast-15345.9
 
GemVax&KAEL Co.Ltd ( KQ Korea Symbol : 082270 )
Sector : N/A And Other Stocks in Same Sector
 
082270 Other Details
Segment EQ
Market Capital 679555432448.00
Sector
Industry
Offical website >
 
082270 Address
082270
 
082270 Latest News
 
Your Comments and Response on GemVax&KAEL Co.Ltd
 
082270 Business Profile
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea. Address: 58 Techno 11-ro, Daejeon, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service